Dietary supplement claims "getting out of control," FDA's Roger Williams tells NDMA.
This article was originally published in The Tan Sheet
Executive Summary
DIETARY SUPPLEMENT CLAIMS "GETTING OUT OF CONTROL," FDA's WILLIAMS said Oct. 10 at the Nonprescription Drug Manufacturers Association's annual manufacturing controls seminar in Philadelphia. Roger Williams, MD, Center for Drug Evaluation & Research deputy director for Pharmaceutical Research, expressed FDA's continued frustration with the Dietary Supplement Health & Education Act, noting that the act has presented "a challenge to the center and to the agency."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning